How much did Biomatter raise?

Biomatter raised $18M at Series A, announced 12 November 2026.

Who founded Biomatter?

Laurynas Karpus is Co-founder & CEO of Biomatter.

What does Biomatter do?

Biomatter operates in HealthTech and is based in Lithuania.

FundedStartupsDaily / HealthTech / Biomatter

Biomatter raises $18M

Biomatter announced a Series A round of $18M on 12 November 2026. The company operates in HealthTech and is based in Lithuania. It was founded by Laurynas Karpus, Co-founder & CEO. Announced yesterday.

Raised

$18M

Stage

Series A

Industry

HealthTech

Country

Lithuania

Founder

Laurynas Karpus

Co-founder & CEO, Biomatter

LinkedIn profile biomatter.com

Outreach angles

-Laurynas Karpus is co-founder and CEO of Biomatter, which designs custom enzymes computationally rather than modifying natural ones.
-Karpus says the goal is to make a custom enzyme as easy to order as a catalogue product.
-The oversubscribed $18M Series A, led by Astanor, funds a 2,000 sq m enzyme design and testing facility in Vilnius opening in 2027 and a larger US commercial team.